Bravelle Fertility Drug Allegedly Ineffective

Were you looking for Bravelle Infertility Drug lawsuits?
- by

Vancouver, Canada: Fertility drug maker Swiss-based Ferring Pharmaceuticals is facing allegations that certain batches of its fertility drug, Bravelle, are defective. In October 2015, Ferring announced that four lots of Bravelle, sold between 2014 and 2015 in the US and Canada, had displayed "reduced potency" in tests. This reduced potency could result in reduced therapeutic effect.

According to the allegations, although following the treatment plan, which cost CDN $14,000, 36-year old Amanda Olthuis was unable to conceive. The IVF cycle failed and the batch of Bravelle that Olthuis used was recalled.

Bravelle is designed to help women's ovaries produce more eggs, often in combination with another hormone for growth and ovulation, as part of a cycle of in vitro fertilization.

Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form on the right and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Add Your Comment on This Issue

Please read our comment guidelines before posting.

Note: Your name will be published with your comment.

Your email will only be used if a response is needed.

Request Legal Help